Drug intelligence / Profile preview

Curcumin BioBDMC30

Development stage
Unknown
Lead developer
Biologic Pharmamedical
Modality
Small Molecules
Administration
Oral
01

Overview

Curcumin BioBDMC30 is a patented curcumin extract with an exceptionally high concentration of bisdemethoxycurcumin (BDMC), typically at 30% compared to the 0.5–1.5% found in standard curcumin extracts. This enhanced formulation is designed for faster and more effective anti-inflammatory results by targeting key proteins involved in inflammation at the genetic and subcellular level. Specifically, BDMC inhibits both NF-kB and MSK1 proteins—regular curcumin only inhibits NF-kB—providing a dual mechanism for combating inflammation[1][5][6]. The product also exhibits extremely high antioxidant activity as measured by ORAC value (oxygen radical absorbance capacity), far exceeding that of regular curcumin[1][5]. It is marketed for managing inflammation, joint pain, discomfort, supporting recovery from injuries or workouts, and promoting cognitive health due to its ability to reduce brain inflammation[6].

Brand names
NovoCurcumin BioBDMC30Curcumin 30+
Other names
Bio-BDMC™30BDMC30BDMC-30BDMC 30BDM30BDM-30BDM 30
02

Targets

MKNK1 (Mitogen‑activated protein kinase‑interacting serine/threonine-protein kinase 1)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)

Beyond the preview

Go deeper on Curcumin BioBDMC30.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Curcumin BioBDMC30.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call